CA2046337A1 - Improved transdermal system for the administration of pharmacological compounds under ph-controlled conditions - Google Patents

Improved transdermal system for the administration of pharmacological compounds under ph-controlled conditions

Info

Publication number
CA2046337A1
CA2046337A1 CA002046337A CA2046337A CA2046337A1 CA 2046337 A1 CA2046337 A1 CA 2046337A1 CA 002046337 A CA002046337 A CA 002046337A CA 2046337 A CA2046337 A CA 2046337A CA 2046337 A1 CA2046337 A1 CA 2046337A1
Authority
CA
Canada
Prior art keywords
administration
controlled conditions
compounds under
transdermal system
pharmacological compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002046337A
Other languages
French (fr)
Other versions
CA2046337C (en
Inventor
Arun Rajaram Gupte
Uwe Rohr
Bernd Zierenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2046337A1 publication Critical patent/CA2046337A1/en
Application granted granted Critical
Publication of CA2046337C publication Critical patent/CA2046337C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00Devices for applying media, e.g. remedies, on the human body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to an improved transdermal administration of pharmacologically active compounds.
CA002046337A 1989-12-01 1990-11-29 Improved transdermal system for the administration of pharmacological compounds under ph-controlled conditions Expired - Lifetime CA2046337C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3939703A DE3939703C2 (en) 1989-12-01 1989-12-01 Improved transdermal application of pharmacologically active compounds
DEP3939703.3 1989-12-01
PCT/EP1990/002052 WO1991007998A1 (en) 1989-12-01 1990-11-29 IMPROVED SYSTEM FOR THE TRANSDERMAL APPLICATION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS AT CONTROLLED pH

Publications (2)

Publication Number Publication Date
CA2046337A1 true CA2046337A1 (en) 1991-06-02
CA2046337C CA2046337C (en) 2004-05-25

Family

ID=6394557

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002046337A Expired - Lifetime CA2046337C (en) 1989-12-01 1990-11-29 Improved transdermal system for the administration of pharmacological compounds under ph-controlled conditions

Country Status (20)

Country Link
EP (1) EP0456792B1 (en)
JP (1) JPH04506811A (en)
KR (1) KR0143549B1 (en)
AT (1) ATE185492T1 (en)
AU (1) AU637861B2 (en)
CA (1) CA2046337C (en)
DE (2) DE3939703C2 (en)
DK (1) DK0456792T3 (en)
ES (1) ES2139570T3 (en)
FI (1) FI107707B (en)
GR (1) GR3032175T3 (en)
HU (1) HU206993B (en)
IE (1) IE904322A1 (en)
IL (1) IL96506A (en)
NO (1) NO302156B1 (en)
NZ (1) NZ236280A (en)
PT (1) PT96045B (en)
RU (1) RU1834665C (en)
WO (1) WO1991007998A1 (en)
ZA (1) ZA909624B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790688B2 (en) 2001-12-21 2014-07-29 Coloplast A/S Wound care device for local treatment of pain in a wound

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
JP3526887B2 (en) * 1993-04-23 2004-05-17 帝國製薬株式会社 Anti-inflammatory analgesic external patch
US6395292B2 (en) 1996-02-02 2002-05-28 Alza Corporation Sustained delivery of an active agent using an implantable system
CN110090206A (en) * 2018-01-30 2019-08-06 日东电工株式会社 Percutaneous absorption type preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4756710A (en) * 1985-04-05 1988-07-12 Merck & Co., Inc. pH-Mediated drug delivery system
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device
US4830856A (en) * 1987-01-27 1989-05-16 Peppers James M Chelation product
ES2062093T3 (en) * 1988-08-02 1994-12-16 Ciba Geigy Ag PLASTER OF SEVERAL LAYERS.
ZA899112B (en) * 1988-12-01 1990-08-29 Schering Corp Compositions for transdermal delivery of estradiol
DE3843557A1 (en) * 1988-12-23 1990-06-28 Beiersdorf Ag Transdermal therapeutic system for administering clenbuterol

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790688B2 (en) 2001-12-21 2014-07-29 Coloplast A/S Wound care device for local treatment of pain in a wound

Also Published As

Publication number Publication date
IE904322A1 (en) 1991-06-05
NO912985L (en) 1991-07-31
JPH04506811A (en) 1992-11-26
RU1834665C (en) 1993-08-15
NO302156B1 (en) 1998-02-02
FI107707B (en) 2001-09-28
PT96045B (en) 1998-01-30
EP0456792A1 (en) 1991-11-21
HU206993B (en) 1993-03-01
CA2046337C (en) 2004-05-25
ES2139570T3 (en) 2000-02-16
EP0456792B1 (en) 1999-10-13
GR3032175T3 (en) 2000-04-27
NO912985D0 (en) 1991-07-31
KR0143549B1 (en) 1998-07-01
DE3939703A1 (en) 1991-06-06
FI913645A0 (en) 1991-07-31
KR920700704A (en) 1992-08-10
HUT59615A (en) 1992-06-29
PT96045A (en) 1991-09-13
NZ236280A (en) 1994-06-27
DE3939703C2 (en) 1998-07-02
HU912638D0 (en) 1992-01-28
IL96506A (en) 1996-01-19
DE59010885D1 (en) 1999-11-18
DK0456792T3 (en) 2000-04-03
AU6875791A (en) 1991-06-26
AU637861B2 (en) 1993-06-10
WO1991007998A1 (en) 1991-06-13
IL96506A0 (en) 1991-08-16
ZA909624B (en) 1992-08-26
ATE185492T1 (en) 1999-10-15

Similar Documents

Publication Publication Date Title
FI872379A7 (en) Process for the preparation of pharmacologically active 1,5-diaryl-3-(ω-substituted-lower-alkyl)-pyrazoles
NO831679L (en) PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE 1,3-DIOXAN-5-YL-ALKENIC ACIDS
FI20000085L (en) Process for the preparation of therapeutically active 4-amino-substituted 2-azabicyclo[3.3.1]nonane derivatives
NO178926C (en) Analogous process for the preparation of pharmacologically active pyrimidine compounds
NO850521L (en) PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE DIESTERS
GB8712437D0 (en) Pharmacologically active compounds
NO900032D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIAZOL COMPOUNDS.
NO173873C (en) Analogous procedure for the preparation of a therapeutically active monosaccharide compound
AU1032992A (en) Pharmacologically active substituted oxybenzamides
NO173503C (en) Analogous Procedure for Preparation of Therapeutically Active Tetrahydroimidayo (1,4) Benzodiazepine-2-tions
FI890841A7 (en) Process for the preparation of novel therapeutically active substituted 7-hydroxy-2,3,4,5-tetrahydro-1H-3-benzazepine carbamic acid esters
NO177096C (en) Analogous process for the preparation of therapeutically active, substituted isoquinolines
AU1413488A (en) Pharmacologically active peptides
CA2046337A1 (en) Improved transdermal system for the administration of pharmacological compounds under ph-controlled conditions
EP0365678A4 (en) 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND USE THEREOF.
NO167668C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE EPIPODOPHYLLOTOXING LUCOSIDE-4'-ACYL DERIVATIVES.
FI853343A7 (en) Process for the preparation of pharmaceutically active phenylacetonitrile derivatives.
NO871190D0 (en) PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE SUBSTITUTED ANILIDES.
NO880922D0 (en) PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE BENZODIOX OLD DERIVATIVES.
FI893121L (en) Process for the preparation of pharmacologically active 6,21-dimethyl-19-norprogesterone derivatives
FR2622446B1 (en) AGENT FOR REDUCING NEPHROTOXICITY PRODUCED BY THE ADMINISTRATION OF CYCLOSPORIN
NO882256D0 (en) PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE QUINOL COMPOUNDS.
GB8622090D0 (en) Pharmacologically active compounds
NO175780C (en) Analogous Process for the Preparation of Therapeutically Active Substituted Dibenzofurans
FI854985A7 (en) A process for the preparation of pharmaceutically active N-substituted aziridine-2-carboxylic acid derivatives.

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry